A Case of Plasmacytoid Dendritic Cell Leukemia

1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edition. Bosman FT, Jaffe ES, LakhaniSR, Ohgaki H. Lyon, France: International Agency for Research on Cancer. 2008.Search in Google Scholar

2. Garnache-Ottou F, Feuillard J, Saas P. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity? Br J Haematol 2007, 136:539-548.10.1111/j.1365-2141.2006.06458.x17367408Search in Google Scholar

3. Lúcio P, Parreira A, Orfao A. CD123hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma. Ann Intern Med. 1999;131:549-550.10.7326/0003-4819-131-7-199910050-0003510507983Search in Google Scholar

4. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.10.1182/blood-2004-09-350215692063Search in Google Scholar

5. Charles J, Chaperot L, Salameire D, et al. Plasmacytoid dendritic cells and dermatological disorders: focus on their role in autoimmunity and cancer. Eur J Dermatol. 2010;20(1):16-23.10.1684/ejd.2010.0816288195519850548Search in Google Scholar

6. Jegalian AG, Buxbaum NP, Facchetti F, et al. Blastic plasmocytoid dendritic cell neoplasm in children: diagnostic feature and clinical presentations. Haematologica. 2010;95(11):1873-1879.10.3324/haematol.2010.026179296690920663945Search in Google Scholar

7. Facchetti F, Ungari M, Marocolo D, Lonardi S, Vermi W. Blastic plasmocytoid dendritic cell neoplasm. Hematology Meeting Reports. 2009;3(3):1-3.Search in Google Scholar

8. Jacob MC, Chaperot L, Mossuz P, et al. CD4+ CD56+ lineage negative malignancies: a new entity developed from malignant early plasmacytoid dendritic cells. Haematologica. 2003;88(8):941-955.Search in Google Scholar

9. Rauh MJ, Rahman F, Good D, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review. Leuk Res. 2012;36:81-86.10.1016/j.leukres.2011.07.03321890199Search in Google Scholar

10. Cota C, Vale E, Viana I, et al. Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients. Am J Surg Pathol. 2010;34(1):75-87.10.1097/PAS.0b013e3181c5e26b19956058Search in Google Scholar

11. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol. 2005;123:662-675.10.1309/GJWNPD8HU5MAJ837Search in Google Scholar

12. Garnache-Ottou F, Feuillard J, Ferrand C, et al. GOELAMS and GEIL study - Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol. 2009;145:624-636.10.1111/j.1365-2141.2009.07679.x19388928Search in Google Scholar

13. Reimer P, Rüdiger T, Kraemer D, et al. What is CD4+CD56+ malignancy and how should it be treated? Bone Marrow Transplant. 2003;32:637-646.Search in Google Scholar

14. Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood. 2002;99:1556-1563.10.1182/blood.V99.5.1556Search in Google Scholar

15. Dietrich S, Andrulis M, Hegenbart U, et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant. 2011;17:1250-1254. 10.1016/j.bbmt.2010.12.70621215813Search in Google Scholar

16. Bueno C, Almeida J, Lucio P, et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica. 2004;89(1):58-69.Search in Google Scholar

17. Béné MC. Biphenotypic, bilineal, ambiguous or mixed lineage: strange leukemias! Haematologica. 2009;94(7):891-893.Search in Google Scholar

18. Reineks EZ, Osei ES, Rosenberg A, Auletta J, Meyerson HJ. CD22 expression on blastic plasmacytoid dendritic cell neoplasms and reactivity of anti-CD22 antibodies to peripheral blood dendritic cells. Cytometry B Clin Cytom. 2009;76(4):237-248.10.1002/cyto.b.2046919382197Search in Google Scholar

19. Suzuki R, Suzumiya J, Yamaguchi M, et al. NK-cell Tumor Study Group - Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol. 2010;21(5):1032-40. 10.1093/annonc/mdp41819850638Search in Google Scholar